Sharon Townson Monte Rosa Therapeutics, Inc. (GLUE) insider trading activity

GLUE Quotes by TradingView

Sharon Townson is Chief Scientific Officer of Monte Rosa Therapeutics, Inc.. Currently has a direct ownership of 67,845 shares of GLUE, which is worth approximately $974,254. The most recent transaction as insider was on Jan 05, 2026, when has been sold 3,155 shares (Common Stock) at a price of $15.17 per share, resulting in proceeds of $47,861. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 67.8K
88.46% 3M change
88.46% 12M change
Total Value Held $974,254

Sharon Townson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 05 2026
SELL
Open market or private sale
$47,861 $15.17 p/Share
3,155 Reduced 4.44%
67,845 Common Stock
Jan 02 2026
BUY
Grant, award, or other acquisition
-
35,000 Added 33.02%
71,000 Common Stock
Jan 02 2025
BUY
Grant, award, or other acquisition
-
36,000 Added 50.0%
36,000 Common Stock
ST

Sharon Townson

Chief Scientific Officer
Boston, MA

Track Institutional and Insider Activities on GLUE

Follow Monte Rosa Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GLUE shares.

Notify only if

Insider Trading

Get notified when an Monte Rosa Therapeutics, Inc. insider buys or sells GLUE shares.

Notify only if

News

Receive news related to Monte Rosa Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GLUE